iGuide Intervention (Self-guided) for Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cancer+17 MoreiGuide Intervention (Self-guided) - Behavioral
Eligibility
18 - 79
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new way of managing care for cancer patients with comorbidities. 800 patients will be randomly assigned to either usual care or care that includes their primary care physician as an active member of their cancer care team. The goal is to improve chronic disease management and communication among cancer survivors.

Eligible Conditions
  • High Blood Pressure
  • Cancer
  • Endometrial Cancer
  • Liver Cancer
  • Renal Cell Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Diabetes
  • Pancreatic Cancer
  • Prostate Cancer
  • Esophageal Cancer
  • High Cholesterol
  • Head and Neck Cancer
  • Non-Small Cell Lung Cancer
  • Cardiovascular Disease

Treatment Effectiveness

Study Objectives

6 Primary · 6 Secondary · Reporting Duration: 18 months

12 months
PCP-reported care coordination
18 months
Clinical laboratory values
Financial burden
HEDIS quality measure of management hypertension
HEDIS quality measure of management of diabetes
HEDIS quality measure of management of statin use
Medication adherence
Medication adherence defined through patient self-report
Patient activation
Patient-Centered Communication in Cancer Care
Patient-reported care coordination
Provider-reported care coordination
90 days
Diversity supplement : 90-day postoperative cardiovascular complications
Risk index for cardiovascular complications

Trial Safety

Trial Design

2 Treatment Groups

iGuide Intervention
1 of 2
Control
1 of 2

Experimental Treatment

800 Total Participants · 2 Treatment Groups

Primary Treatment: iGuide Intervention (Self-guided) · No Placebo Group · N/A

iGuide InterventionExperimental Group · 2 Interventions: iGuide Intervention (Self-guided), iGuide 2 Intervention (Tailored/Targeted) · Intervention Types: Behavioral, Behavioral
Control
Behavioral
Experimental Group · 1 Intervention: Control · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control
2011
Completed Phase 4
~15680

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 18 months

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,173 Previous Clinical Trials
3,199,127 Total Patients Enrolled

Eligibility Criteria

Age 18 - 79 · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a physician who has provided care to ≥1 older adult patient who has undergone cancer surgery within a 12-month period at Duarte University Health System.
You have at least one of three CVD comorbidities (hypertension, diabetes, or hypercholesterolemia) - based upon whether the patient is currently on a medication for the comorbidity at time of recruitment.
This study is evaluating whether older adults with cancer who have CVD are more likely to have complications after surgery.